To evaluate the prognostic value of proliferative maker Ki-67, its expression was determined immunohistochemically in 37 gallbladder carcinomas (GBCs). A high Ki-67 index was significantly correlated with tumor lymphatic invasion (P=0.007) and vascular invasion (P=0.04). High Ki-67 index group and low Ki-67 index group showed different clinical courses. Five patients who experienced recurrences in high Ki-67 index group developed their recurrent diseases within one year after surgery and died soon after recurrence, while the recurrences (five cases) in low Ki-67 index group were distributed all stages after surgery. In conclusion, high Ki-67 index predicts early recurrence after surgery for GBC
Background: Upper tract urinary carcinoma (UTUC) is a relatively uncommon but aggressive disease. Th...
The tumor proliferation index marker Ki-67 is strongly associated with tumor cell proliferation, gro...
In Ukraine 60,9% of patients with gastric cancer die within 1 year after ascertainment of diagnosis....
INTRODUCTION: Gallbladder cancer is an aggressive cancer with short median survival from the time of...
The growth of tumors is highly variable and this probably reflects even its clinical course. The mon...
Background: Ki-67 expression is strictly associated with cellular proliferation and is an excellent ...
BackgroundThe overexpression of p53 protein and the expression of Ki‐67 antigen may affect the survi...
Various clinicopathological factors are evaluated in different studies on carcinomas to demonstrate ...
Litvinenko О. О., Bugaichov S. G., Litvinenko О. О. Ki-67 MARKER OF TUMORS PROLIFERATION AS PROGNOST...
BACKGROUND: We sought to determine the significance of Ki-67, one of the tumor cell proliferation ma...
Hepatocellular carcinoma is one of the most common cancers worldwide and a major cause of death in m...
p27(Kip1) is a cyclin-dependent kinase inhibitor that negatively regulates cell proliferation. This ...
The aim of study was to investigate the expression of the proliferation factor Ki-67 and its relatio...
In order to define new prognostic factors useful for therapeutic decision-making, the Authors conduc...
The aim of this study was to determine the prognostic value of Ki-67 immunostaining in patients affe...
Background: Upper tract urinary carcinoma (UTUC) is a relatively uncommon but aggressive disease. Th...
The tumor proliferation index marker Ki-67 is strongly associated with tumor cell proliferation, gro...
In Ukraine 60,9% of patients with gastric cancer die within 1 year after ascertainment of diagnosis....
INTRODUCTION: Gallbladder cancer is an aggressive cancer with short median survival from the time of...
The growth of tumors is highly variable and this probably reflects even its clinical course. The mon...
Background: Ki-67 expression is strictly associated with cellular proliferation and is an excellent ...
BackgroundThe overexpression of p53 protein and the expression of Ki‐67 antigen may affect the survi...
Various clinicopathological factors are evaluated in different studies on carcinomas to demonstrate ...
Litvinenko О. О., Bugaichov S. G., Litvinenko О. О. Ki-67 MARKER OF TUMORS PROLIFERATION AS PROGNOST...
BACKGROUND: We sought to determine the significance of Ki-67, one of the tumor cell proliferation ma...
Hepatocellular carcinoma is one of the most common cancers worldwide and a major cause of death in m...
p27(Kip1) is a cyclin-dependent kinase inhibitor that negatively regulates cell proliferation. This ...
The aim of study was to investigate the expression of the proliferation factor Ki-67 and its relatio...
In order to define new prognostic factors useful for therapeutic decision-making, the Authors conduc...
The aim of this study was to determine the prognostic value of Ki-67 immunostaining in patients affe...
Background: Upper tract urinary carcinoma (UTUC) is a relatively uncommon but aggressive disease. Th...
The tumor proliferation index marker Ki-67 is strongly associated with tumor cell proliferation, gro...
In Ukraine 60,9% of patients with gastric cancer die within 1 year after ascertainment of diagnosis....